Consistent with this idea, the B4GALT1 enhancer SVA insertion is linked to a genomic region implicated by GWAS in both inflammatory conditions and autoimmune diseases such as systemic lupus erythematosus and Crohn’s disease (Lauc et al., 2013). Here, B4GALT1 is linked to autoimmune disease.